Pasithea Therapeutics

Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health. The company is led by renowned immunologists based at Stanford University and their academic research is headed by a top psychiatric academic at King’s College London. The long-term aim is to translate research into clinic-ready drugs. Pasithea Therapeutics' secondary operations focus on establishing anti-depression clinics and mobile clinics across the US and UK, using trained pharmacists to administer intravenous infusions of ketamine. Pasithea has partnered with two successful clinics (THE IV DOC and Zen Health) for immediate exposure in locations across Los Angeles, New York City, and London.

Pasithea Therapeutics is one of 16 Biotechnology companies we track in South Florida — 2% of the region's 662 startups.